Problems › Business Transformation Consulting › Retail
Most retail portfolio reviews miss the mark when assessing which stores cover their occupancy costs, and that assessment is typically commissioned from the same advisors positioned to staff the resulting lease decisions. Retailers carry a specific bind here — 22 leases expire within 24 months and nobody can say which stores are actually profitable. Until that is priced, four-wall margin will keep moving for reasons nobody can attribute, and the debate about programme spend to date will stay a matter of opinion.
Most retail portfolio reviews miss the mark when assessing which stores cover their occupancy costs, and that assessment is typically commissioned from the same advisors positioned to staff the resulting lease decisions. Retailers carry a specific bind here — 22 leases expire within 24 months and nobody can say which stores are actually profitable. Until that is priced, four-wall margin will keep moving for reasons nobody can attribute, and the debate about programme spend to date will stay a matter of opinion.
A store portfolio review bundles three separable things: determining which locations produce positive four-wall margin after all occupancy costs, deciding which of the 22 expiring leases to renew or exit, and supplying the capacity to execute closures or remodels. Firms combine the steps because the initial margin analysis is priced low and recovers value by defining the scope of follow-on work, so the reviewers gain if the set of underperforming stores appears large.
Repeated shortfalls in these reviews trace to the same early step: questions about sales per square foot and traffic density by location get reframed as project timelines before the underlying contribution of each store is isolated. When the arithmetic on which sites fund the rest of the chain is not settled first, the plan proceeds on incomplete store-level data.
The working test is whether the CFO can already list the stores ordered by four-wall margin, sales per square foot, and occupancy cost ratio, with a clear sequence for the leases due in the next 24 months. If that list exists, the need is execution capacity; if it does not, further spend on delivery teams only locks in changes whose net effect on overall margin remains unknown.
Corporate Strategy & Transformation produces the missing comparison: an allocation of revenue and costs across the 40 stores that shows which locations carry the occupancy burden and which changes should precede others. It stops at that ranking and states plainly when outside delivery resources are required, avoiding the first engagement that would otherwise define its own larger scope.
These three together are the signature. One on its own usually points somewhere else.
✓ Lease expiration dates appear on the calendar while the latest four-wall margin figures remain aggregated at chain level rather than by individual site.
✓ A project timeline lists workstreams by region or format before any store-by-store ranking of sales per square foot and occupancy cost ratio has been produced.
✓ Discussions of ship-from-store or co-tenancy clauses begin while the owner still lacks a short list of locations ordered by their contribution after all direct costs.
The move that usually makes it worse. Commissioning the lease and margin review from the same firm that will later propose and staff the closures or remodel programme, which aligns the scope of recommended changes with the volume of work that firm can supply.
It is for you if you run or finance a retailer and the word "transformation" is being used before anyone has agreed what is broken. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a retailer. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Marlin & Crowe, a sample company profile used for testing rather than a customer — $95M revenue, 40 stores.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Turn the 21 most profitable stores and 410k loyalty members into a closed-loop private-label growth and fulfillment engine that funds itself.
| Investment required | $1.8-2.2M total (Phase 1: $500-700K; Phase 2: $800K-1.0M; Phase 3: $500-700K) — fully funded from existing $7.8M cash and $22M revolver headroom without external capital raise |
| Expected return | Base case: 2.8× cash-on-cash return over 36 months ($5.0-6.2M incremental EBITDA vs. $1.8-2.2M investment). |
| Revenue, year 1 | $218-222M (flat to +3% vs. FY2025 $215M baseline) — private-label mix rises from 32% to 35% in destination stores only |
| Revenue, year 2 | $225-232M (+5-8% vs. FY2025) — BOPIS penetration reaches 50%, private-label mix reaches 38% |
| Revenue, year 3 | $235-245M (+9-14% vs. FY2025) — BOPIS penetration reaches 60%, private-label mix reaches 40%, 2-3 new destination. |
| Exit criteria | Strategy should be abandoned or materially pivoted if, within 12 months, (a) BOPIS fill rate in pilot stores remains below 70% after WMS/RFID deployment, OR (b) new private-label SKUs achieve <15% sell-through in destination stores after two seasonal cycles, OR (c) incremental gross margin from. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For retailers it works through four-wall margin, sales per square foot, occupancy cost ratio and traffic density, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
For a mid-market company the diagnostic phase alone is commonly £75k–£250k over six to ten weeks, and the delivery phase that follows is usually several multiples of that. Large-firm day rates run roughly £1,500–£3,500 for a consultant and £4,000–£8,000 for a partner, and a typical team blends the two so the effective rate lands somewhere in the middle. The number that matters is not the day rate, though — it is the ratio of diagnosis to delivery, because that is where the scope is set.
No, and any tool that claims otherwise is selling you something. Software cannot run a programme office, hold a difficult conversation with a divisional MD, or supply forty people for nine months. What it can do is produce the analysis that decides whether you need those things, and what they should be pointed at — which is the part that is most often rushed and most expensive to get wrong.
Buy the diagnosis separately from whoever will deliver, and write the decision down before you take delivery bids. Once the two or three changes are named and the arithmetic is on paper, the delivery tender is a procurement exercise with a fixed brief. Once they are not, the tender sets its own brief, and it is always a larger one.
Materially, yes. 22 leases expire within 24 months and nobody can say which stores are actually profitable — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are four-wall margin, sales per square foot, occupancy cost ratio, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on four-wall margin and sales per square foot. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית